Cc1nn(CC(=O)Nc2sc3c(c2C#N)CCCC3)c(C)c1I
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?